Julia Aniscenko

3.0k total citations
17 papers, 1.4k citations indexed

About

Julia Aniscenko is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Julia Aniscenko has authored 17 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 8 papers in Epidemiology. Recurrent topics in Julia Aniscenko's work include Asthma and respiratory diseases (10 papers), Respiratory viral infections research (8 papers) and Pediatric health and respiratory diseases (8 papers). Julia Aniscenko is often cited by papers focused on Asthma and respiratory diseases (10 papers), Respiratory viral infections research (8 papers) and Pediatric health and respiratory diseases (8 papers). Julia Aniscenko collaborates with scholars based in United Kingdom, United States and Italy. Julia Aniscenko's co-authors include Sebastian L. Johnston, Tatiana Kebadze, Patrick Mallia, Michael R. Edwards, Nathan W. Bartlett, L Stanciu, Onn Min Kon, Alberto Papi, Simon Message and Malcolm Johnson and has published in prestigious journals such as Nature Medicine, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Julia Aniscenko

17 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Aniscenko United Kingdom 13 656 561 433 420 311 17 1.4k
Ivana Morić Germany 7 719 1.1× 474 0.8× 536 1.2× 183 0.4× 232 0.7× 9 1.2k
Ross P. Walton United Kingdom 19 359 0.5× 755 1.3× 485 1.1× 757 1.8× 210 0.7× 31 1.5k
Gwendolyn Sanderson United Kingdom 7 998 1.5× 903 1.6× 866 2.0× 362 0.9× 378 1.2× 8 1.8k
Maria‐Belen Trujillo‐Torralbo United Kingdom 12 489 0.7× 225 0.4× 366 0.8× 265 0.6× 240 0.8× 18 996
Vera Gielen United Kingdom 5 288 0.4× 286 0.5× 305 0.7× 239 0.6× 143 0.5× 10 722
Melissa Baraket Australia 14 659 1.0× 867 1.5× 132 0.3× 282 0.7× 174 0.6× 21 1.2k
I. Carla Lohman United States 17 378 0.6× 837 1.5× 253 0.6× 599 1.4× 230 0.7× 28 1.6k
Vijay Mistry United Kingdom 17 1.1k 1.6× 1.1k 2.0× 124 0.3× 450 1.1× 285 0.9× 44 1.7k
Heidi Makrinioti United Kingdom 15 280 0.4× 369 0.7× 185 0.4× 295 0.7× 83 0.3× 40 946
Daniel Droemann Germany 15 366 0.6× 202 0.4× 260 0.6× 452 1.1× 112 0.4× 18 1.1k

Countries citing papers authored by Julia Aniscenko

Since Specialization
Citations

This map shows the geographic impact of Julia Aniscenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Aniscenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Aniscenko more than expected).

Fields of papers citing papers by Julia Aniscenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Aniscenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Aniscenko. The network helps show where Julia Aniscenko may publish in the future.

Co-authorship network of co-authors of Julia Aniscenko

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Aniscenko. A scholar is included among the top collaborators of Julia Aniscenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Aniscenko. Julia Aniscenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Antunes, Krist Helen, Aran Singanayagam, Ana Farı́as, et al.. (2022). Airway-delivered short-chain fatty acid acetate boosts antiviral immunity during rhinovirus infection. Journal of Allergy and Clinical Immunology. 151(2). 447–457.e5. 35 indexed citations
2.
Farne, Hugo, Nicholas Glanville, Nicholas Johnson, et al.. (2021). Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trial. Thorax. 77(10). 950–959. 9 indexed citations
3.
Zhu, Jie, Patrick Mallia, Joseph Footitt, et al.. (2020). Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD. Journal of Allergy and Clinical Immunology. 146(4). 840–850.e7. 14 indexed citations
4.
Kamal, Faisal, Nicholas Glanville, Eteri Bakhsoliani, et al.. (2020). Beclomethasone Has Lesser Suppressive Effects on Inflammation and Antibacterial Immunity Than Fluticasone or Budesonide in Experimental Infection Models. CHEST Journal. 158(3). 947–951. 4 indexed citations
5.
Finney, Lydia, Nicholas Glanville, Hugo Farne, et al.. (2020). Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon. Journal of Allergy and Clinical Immunology. 147(2). 510–519.e5. 100 indexed citations
6.
Calderazzo, Maria Adelaide, Maria‐Belen Trujillo‐Torralbo, Lydia Finney, et al.. (2019). <p>Inflammation and infections in unreported chronic obstructive pulmonary disease exacerbations</p>. International Journal of COPD. Volume 14. 823–833. 12 indexed citations
7.
Toussaint, Marie, David J. Jackson, Dawid Swieboda, et al.. (2017). Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation. Nature Medicine. 23(6). 681–691. 243 indexed citations
8.
Glanville, Nicholas, et al.. (2016). Tbet Deficiency Causes T Helper Cell Dependent Airways Eosinophilia and Mucus Hypersecretion in Response to Rhinovirus Infection. PLoS Pathogens. 12(9). e1005913–e1005913. 17 indexed citations
9.
Aab, Alar, Oliver F. Wirz, Willem van de Veen, et al.. (2016). Human rhinoviruses enter and induce proliferation of B lymphocytes. Allergy. 72(2). 232–243. 24 indexed citations
10.
Footitt, Joseph, Patrick Mallia, Andrew Durham, et al.. (2015). Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD. CHEST Journal. 149(1). 62–73. 56 indexed citations
11.
Singanayagam, Aran, Nicholas Glanville, Ross P. Walton, et al.. (2015). A short-term mouse model that reproduces the immunopathological features of rhinovirus-induced exacerbation of COPD. Clinical Science. 129(3). 245–258. 32 indexed citations
12.
Mallia, Patrick, Joseph Footitt, Annette Jepson, et al.. (2012). Rhinovirus Infection Induces Degradation of Antimicrobial Peptides and Secondary Bacterial Infection in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 186(11). 1117–1124. 194 indexed citations
13.
Bartlett, Nathan W., Louise Slater, Nicholas Glanville, et al.. (2012). Defining critical roles for NF‐κB p65 and type I interferon in innate immunity to rhinovirus. EMBO Molecular Medicine. 4(12). 1244–1260. 64 indexed citations
14.
Mallia, Patrick, Joseph Footitt, Annette Jepson, et al.. (2011). Rhinovirus infection induces secondary bacterial infection in COPD. 38. 196. 1 indexed citations
15.
Mallia, Patrick, Simon Message, Vera Gielen, et al.. (2010). Experimental Rhinovirus Infection as a Human Model of Chronic Obstructive Pulmonary Disease Exacerbation. American Journal of Respiratory and Critical Care Medicine. 183(6). 734–742. 289 indexed citations
16.
Bisgaard, Hans, Mette N. Hermansen, Klaus Bønnelykke, et al.. (2010). Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study. BMJ. 341(oct04 1). c4978–c4978. 239 indexed citations
17.
Lim, Sam, Nicholas J. C. King, Nathan W. Bartlett, et al.. (2010). Rhinovirus infection induces expression of airway remodelling factors in vitro and in vivo. Respirology. 16(2). 367–377. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026